Abstract

Toll-like receptors (TLRs) are pattern recognition receptors crucial for the innate and adaptive immune response to pathogen-associated molecular patterns (PAMPs). TLR stimulation via microbial products activates antigen-presenting cells, influences the function of T regulatory cells (Treg), determines the Th1/Th2 balance and Th17 cell differentiation, and controls cytokine production in mast cells and activation of eosinophils. The role of TLR receptors in pathogenesis of allergic diseases results from the biological function that they play in activation and regulation of the immune response. However, the exact role still remains a controversial area. Whereas numerous epidemiological studies mainly indicate a protective effect of microbial exposure, experiments show that innate immune stimulation via TLRs may be involved in both development of and protection against allergic diseases. Timing, dose, site and intensity of exposure to environmental factors and host genetic predisposition are clearly crucial to understanding the interaction between innate immune stimulation and allergy development.Furthermore, extensive clinical trials suggest that ligands for TLRs provide new therapeutic targets for protection against and treatment of asthma and allergic rhinitis.The aim of this review is to summarize the current knowledge about the role of TLRs in pathogenesis of allergic diseases. We will further discuss how we can reconcile inconsistencies in the results of existing studies and review information on the potential use of ligands for TLRs in allergy prevention and therapy.

References

• 1. Ashino S., Wakita D., Zhang Y., Chamoto K., Kitamura H., NishimuraT.: CpG-ODN inhibits airway inflammation at effector phasethrough down-regulation of antigen-specific Th2-cell migration intolung. Int. Immunol., 2008; 20: 259-266 2 Bartlett N.W., Walton R.P., Edwards M.R., Aniscenko J., CaramoriG., Zhu J., Glanville N., Choy K.J., Jourdan P., Burnet J., Tuthill T.J., PedrickM.S., Hurle M.J., Plumpton C., Sharp N.A. i wsp.: Mouse modelsof rhinovirus-induced disease and exacerbation of allergic airwayinflammation. Nat. Med., 2008; 14: 199-204
  Google Scholar
• 2. agonist Pam3CSK4 enhances the induction of antigen-specific tolerancevia the sublingual route. Clin. Exp. Allergy, 2008; 38: 1819-1829
  Google Scholar
• 3. Bauer S., Hangel D., Yu P.: Immunobiology of toll-like receptorsin allergic disease. Immunobiology, 2007; 212: 521-533 4 Belderbos M., Levy O., Bont L.: Neonatal innate immunity in allergydevelopment. Curr. Opin. Pediatr., 2009; 21: 762-769
  Google Scholar
• 4. agonists decrease allergic inflammation. Am. J. Respir. Cell Mol.Biol., 2005; 32: 218-224
  Google Scholar
• 5. Bloomfield S.F., Stanwell-Smith R., Crevel R.W., Pickup J.: Tooclean, or not too clean: the hygiene hypothesis and home hygiene.Clin. Exp. Allergy, 2006; 36: 402-425
  Google Scholar
• 6. Busse W.W., Lemanske R.F. Jr., Gern J.E.: Role of viral respiratoryinfections in asthma and asthma exacerbations. Lancet, 2010;376: 826-834
  Google Scholar
• 7. Conrad M.L., Ferstl R., Teich R., Brand S., Blümer N., YildirimA.O., Patrascan C.C., Hanuszkiewicz A., Akira S., Wagner H., Holst O.,von Mutius E., Pfefferle P.I., Kirschning C.J., Garn H., Renz H.: MaternalTLR signaling is required for prenatal asthma protection bythe nonpathogenic microbe Acinetobacter lwoffi F78. J. Exp. Med.,2009; 206: 2869-2877
  Google Scholar
• 8. Creticos P.S., Schroeder J.T., Hamilton R.G., Balcer-Whaley S.L.,Khattignavong A.P., Lindblad R., Li H., Coffman R., Seyfert V., EidenJ.J., Broide D., Immune Tolerance Network Group: Immunotherapywith a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.N. Engl. J. Med., 2006; 355: 1445-1455
  Google Scholar
• 9. Dahl M.E., Dabbagh K., Liggitt D., Kim S., Lewis D.B.: Viral-inducedT helper type 1 responses enhance allergic disease by effects onlung dendritic cells. Nat. Immunol., 2004; 5: 337-343
  Google Scholar
• 10. Debarry J., Garn H., Hanuszkiewicz A., Dickgreber N., Blümer N.,von Mutius E., Bufe A., Gatermann S., Renz H., Holst O., Heine H.:Acinetobacter lwoffii and Lactococcus lactis strains isolated fromfarm cowsheds possess strong allergy-protective properties. J. AllergyClin. Immunol., 2007; 119: 1514-1521
  Google Scholar
• 11. Debarry J., Hanuszkiewicz A., Stein K., Holst O., Heine H.: Theallergy-protecive properties of Acinetobacter lwoffii F78 are impartedby its lipopolysaccharide. Allergy, 2010; 65: 690-697
  Google Scholar
• 12. Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., HerrickC.A., Bottomly K.: Lipopolysaccharide-enhanced Toll-like receptor4-dependent T helper cell type 2 responses to inhaled antigen. J.Exp. Med., 2002; 196: 1645-1651
  Google Scholar
• 13. Fuchs B., Knothe S., Rochlitzer S., Nassimi M., Greweling M., LauensteinH.D., Nassenstein C., Müller M., Ebensen T., Dittrich A.M., Krug N.,Guzman C.A., Braun A.: A Toll-like receptor 2/6 agonist reduces allergicairway inflammation in chronic respiratory sensitisation to Timothygrass pollen antigens. Int. Arch. Allergy Immunol., 2010; 152: 131-139
  Google Scholar
• 14. Garn H., Renz H.: Epidemiological and immunological evidencefor hygiene hypothesis. Immunobiology, 2007; 212: 441-452
  Google Scholar
• 15. Gerhold K., Avagyan A., Seib C., Frei R., Steinle J., Ahrens B.,Dittrich A.M., Blumchen K., Lauener R., Hamelmann E.: Prenatalinitiation of endotoxin airway exposure prevents subsequent allergen-inducedsensitization and airway inflammation in mice. J.Allergy Clin. Immunol., 2006; 118: 666-673
  Google Scholar
• 16. Goldman M.: Translational mini-review series on Toll-like receptors:Toll-like receptor ligands as novel pharmaceuticals for allergicdisorders. Clin. Exp. Immunol., 2007; 147: 208-216
  Google Scholar
• 17. Gupta G.K., Agrawal D.K.: CpG oligodeoxynucleotides as TLR9agonists: therapeutic application in allergy and asthma. BioDrugs,2010; 24: 225-235
  Google Scholar
• 18. Hammad H., Chieppa M., Perros F., Willart M.A., Germain R.N.,Lambrecht B.N.: House dust mite allergen induces asthma via Toll–like receptor 4 triggering of airway structural cells. Nat. Med., 2009;15: 410-416
  Google Scholar
• 19. Hayashi T., Raz E.: TLR-9 based immunotherapy for allergic disease.Am. J. Med., 2006; 119: 897.e1-897.e6
  Google Scholar
• 20. Hollingsworth J.W., Whitehead G.S., Lin K.L., Nakano H., GunnM.D., Schwartz D.A., Cook D.N.: TLR4 signaling attenuates ongoingallergic inflammetion. J. Immunol., 2006; 176: 5856-5862
  Google Scholar
• 21. Iwamura C., Nakayama T.: Toll-like receptors in the respiratorysystem: their roles in inflammation. Curr. Allergy Asthma Rep.,2008; 8: 7-13
  Google Scholar
• 22. Iwasaki A., Medzhitov R.: Toll-like receptor control of the adaptiveimmune responses. Nat. Immunol., 2004; 5: 987-995
  Google Scholar
• 23. Kanzler H., Barrat F.J., Hessel E.M., Coffman R.L.: Therapeutictargeting of innate immunity with Toll-like receptor agonists andantagonists. Nat. Med., 2007; 13: 552-559
  Google Scholar
• 24. Kato A., Favoreto S. Jr., Avila P.C., Schleimer R.P.: TLR3- and Th2cytokine-dependent production of thymic stromal lymphopoietinin human airway epithelial cells J. Immunol., 2007; 179: 1080-1087
  Google Scholar
• 25. Kim Y.K., Oh S.Y., Jeon S.G., Park H.W., Lee S.Y., Chun E.Y., BangB., Lee H.S., Oh M.H., Kim Y.S., Kim J.H., Gho Y.S., Cho S.H., Min K.U.,Kim Y.Y., Zhu Z.: Airway exposure levels of lipopolysaccharide determinetype 1 versus type 2 experimental asthma. J. Immunol.,2007; 178: 5375-5382
  Google Scholar
• 26. Klimek L., Willers J., Hammann-Haenni A., Pfaar O., Stocker H.,Mueller P., Renner W.A., Bachmann M.F.: Assessment of clinical efficacyof CYT003-QbG10 in patients with allergic rhinoconjunctivitis:a phase IIb study. Clin. Exp. Allergy, 2011; 41: 1305-1312
  Google Scholar
• 27. Kuo C., Lim S., King N.J., Bartlett N.W., Walton R.P., Zhu J., GlanvilleN., Aniscenko J., Johnston S.L., Burgess J.K., Black J.L., OliverB.G.: Rhinovirus infection induces expression of airway remodellingfactors in vitro and in vivo. Respirology, 2011; 16: 367-377
  Google Scholar
• 28. Lam D., Ng N., Lee S., Batzer G., Horner A.A.: Airway house dustextract exposures modify allergen-induced airway hypersensitivityresponses by TLR4-dependent and independent pathways. J. Immunol.,2008; 181: 2925-2932
  Google Scholar
• 29. Liu Y.J.: Thymic stromal lymphopoietin: master switch for allergicinflammation. J. Exp. Med., 2006; 203: 269-273
  Google Scholar
• 30. Lombardi V., Van Overtvelt L., Horiot S., Moussu H., Chabre H.,Louise A., Balazuc A.M., Mascarell L., Moingeon P.: Toll-like receptor
  Google Scholar
• 31. Marsland B.J., Scanga C.B., Kopf M., Le Gros G.: Allergic airwayinflammation is exacerbated during acute influenza infection andcorrelates with increased allergen presentation and recruitmentof allergen-specific T-helper type 2 cells. Clin. Exp. Allergy, 2004;34: 1299-1306
  Google Scholar
• 32. McCormack P.L., Wagstaff A.J.: Ultra-short-course seasonal allergyvaccine (Pollinex Quattro). Drugs, 2006; 66: 931-938
  Google Scholar
• 33. Newcomb D.C., Peebles R.S. Jr.: Bugs and asthma: a differentdisease? Proc. Am. Thorac. Soc., 2009; 6: 266-271
  Google Scholar
• 34. Nigo Y.I., Yamashita M., Hirahara K., Shinnakasu R., Inami M.,Kimura M., Hasegawa A., Kohno Y., Nakayama T.: Regulation of allergicairway inflammation through Toll-like receptor 4-mediatedmodification of mast cell function. Proc. Natl. Acad. Sci. USA, 2006;103: 2286-2291
  Google Scholar
• 35. Ng N., Lam D., Paulus P., Batzer G., Horner A.A.: House dustextracts have both TH2 adjuvant and tolerogenic activities. J. AllergyClin. Immunol., 2006; 117: 1074-1081
  Google Scholar
• 36. Patel M., Xu D., Kewin P., Choo-Kang B., McSharry C., ThomsonN.C., Liew F.Y.: TLR2 agonist ameliorates established allergic airwayinflammation by promoting Th1 response and not via regulatory Tcells. J. Immunol., 2005; 174: 7558-7563
  Google Scholar
• 37. Phipps S., Lam C.E., Kaiko G.E., Foo S.Y., Collison A., Mattes J., BarryJ., Davidson S., Oreo K., Smith L., Mansell A., Matthaei K.I., FosterP.S.: Toll/IL-1 signaling is critical for house dust mite-specific Th1and Th2 responses. Am. J. Respir. Crit. Care Med., 2009; 179: 883-893
  Google Scholar
• 38. Piggott D.A., Eisenbarth S.C., Xu L., Constant S.L., Huleatt J.W.,Herrick C.A., Bottomly K.: MyD88-dependent induction of allergicTh2 responses to intranasal antigen. J. Clin. Invest., 2005; 115:459-467
  Google Scholar
• 39. Redecke V., Häcker H., Datta S.K., Fermin A., Pitha P.M., BroideD.H., Raz E.: Cutting edge: activation of Toll-like receptor 2 inducesa Th2 immune response and promotes experimental asthma. J. Immunol.,2004; 172: 2739-2743
  Google Scholar
• 40. Renner W.A., Beeh K.M., Schilder C., Wagner F., Kanniess F.,Naudts I., Hammann A., Willers J., Mueller P., Bachmann M.: NovelTLR-9 agonist CYT003-QbG10 shown to improve asthma control inplacebo-controlled phase II clinical trial. Am. J. Respir. Crit. CareMed., 183; 2011: A4063
  Google Scholar
• 41. Revets H., Pynaert G., Grooten J., De Baetselier P.: Lipoprotein I,a TLR2/4 ligand modulates Th2-driven allergic immune responses.J. Immunol., 2005; 174: 1097-1103
  Google Scholar
• 42. Romagnani S.: The increased prevalence of allergy and the hygienehypothesis: missing immune deviation, reduced immune suppression,or both? Immunology, 2004; 112: 352-363
  Google Scholar
• 43. Sandor F., Buc M.: Toll-like receptors. II. Distribution and pathwaysinvolved in TLR signalling. Folia Biol., 2005; 51: 188-197
  Google Scholar
• 44. Schaub B., Liu J., Höppler S., Schleich I., Huehn J., Olek S., WieczorekG., Illi S, von Mutius E.: Maternal farm exposure modulatesneonatal immune mechanisms through regulatory T cells. J. AllergyClin. Immunol., 2009; 123: 774-782.e5
  Google Scholar
• 45. Schröder N.W.: The role of innate immunity in the pathogenesisof asthma. Curr. Opin. Allergy Clin. Immunol., 2009; 9: 38-43
  Google Scholar
• 46. Schröder N.W., Crother T.R., Naiki Y., Chen S., Wong M.H., YilmazA., Slepenkin A., Schulte D., Alsabeh R., Doherty T.M., PetersonE., Nel A.E., Arditi M.: Innate immune responses during respiratorytract infection with a bacterial pathogen induce allergic airway sensitization.J. Allergy Clin. Immunol., 2008; 122: 595-602.e5
  Google Scholar
• 47. Sel S., Wegmann M., Sel S., Bauer S., Garn H., Alber G., Renz H.:Immunomodulatory effects of viral TLR ligands on experimentalasthma depend on the additive effects of IL-12 and IL-10. J. Immunol.,2007; 178: 7805-7813
  Google Scholar
• 48. Senti G., Johansen P., Haug S., Bull C., Gottschaller C., Müller P.,Pfister T., Maurer P., Bachmann M.F., Graf N., Kündig T.M.: Use of A–type CpG oligodeoxynucleotides as an adjuvant in allergen-specificimmunotherapy in humans: a phase I/IIa clinical trial. Clin. Exp.Allergy, 2009; 39: 562-570
  Google Scholar
• 49. Sevin C.M., Peebles R.S. Jr.: Infections and asthma: new insightsinto old ideas. Clin. Exp. Allergy, 2010; 40: 1142-1154
  Google Scholar
• 50. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., HorneyB., Gilliet M., Ho S., Antonenko S., Lauerma A., Smith K., Gorman D.,Zurawski S., Abrams J., Menon S., McClanahan T., de Waal-MalefytR., Bazan F., Kastelein R.A., Liu Y.J.: Human epithelial cells triggerdendritic cell mediated allergic inflammation by producing TSLP.Nat. Immunol., 2002; 3: 673-680
  Google Scholar
• 51. Strachan D.P.: Hay fever, hygiene, and household size. BMJ,1989; 299: 1259-1260
  Google Scholar
• 52. Strachan D.P.: Family size, infection and atopy: the first decadeof the “hygiene hypothesis”. Thorax, 2000; 55 (Suppl. 1): S2-S10
  Google Scholar
• 53. Taylor R.C., Richmond P., Upham J.W.: Toll-like receptor 2 ligandsinhibit TH2 responses to mite allergen. J. Allergy Clin. Immunol.,2006; 117: 1148-1154
  Google Scholar
• 54. Trompette A., Divanovic S., Visintin A., Blanchard C., Hegde R.S.,Madan R., Thorne P.S., Wills-Karp M., Gioannini T.L., Weiss J.P., KarpC.L.: Allergenicity resulting from functional mimicry of a Toll-likereceptor complex protein. Nature, 2009; 457: 585-589
  Google Scholar
• 55. Tse K., Horner A.A.: Allergen tolerance versus the allergic march:the hygiene hypothesis revisited. Curr. Allergy Asthma Rep., 2008;8: 475-483
  Google Scholar
• 56. Tulic M.K., Fiset P.O., Christodoulopoulos P., Vaillancourt P.,Desrosiers M., Lavigne F., Eiden J., Hamid Q.: Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreasesthe nasal inflammatory response. J. Allergy Clin. Immunol.,2004; 113: 235-241
  Google Scholar
• 57. Tulic M.K., Fiset P.O., Manoukian J.J., Frenkiel S., Lavigne F.,Eidelman D.H., Hamid Q.: Role of toll-like receptor 4 in protection bybacterial lipopolysaccharide in the nasal mucosa of atopic childrenbut not adults. Lancet, 2004; 363: 1689-1697
  Google Scholar
• 58. Velasco G., Campo M., Manrique O.J., Bellou A., He H., ArestidesR.S., Schaub B., Perkins D.L., Finn P.W.: Toll-like receptor 2 or
  Google Scholar
• 59. Vogel K., Blümer N., Korthals M., Mittelstädt J., Garn H., Ege M.,von Mutius E., Gatermann S., Bufe A., Goldmann T., Schwaiger K.,Renz H., Brandau S., Bauer J., Heine H., Holst O.: Animal shed Bacilluslicheniformis spores possess allergy-protective as well as inflammatoryproperties. J. Allergy Clin. Immunol., 2008; 122: 307-312.e8
  Google Scholar
• 60. von Mutius E.: Allergies, infections and the hygiene hypothesis– the epidemiological evidence. Immunobiology, 2007; 212: 433-439
  Google Scholar
• 61. Wang Q., Nagarkar D.R., Bowman E.R., Schneider D., GosangiB., Lei J., Zhao Y., McHenry C.L., Burgens R.V., Miller D.J., Sajjan U.,Hershenson M.B.: Role of double-stranded RNA pattern recognitionreceptors in rhinovirus-induced airway epithelial cell responses. J.Immunol., 2009; 183: 6989-6997
  Google Scholar
• 62. Wang Y., McCusker C.: Neonatal exposure with LPS and/or allergenprevents experimental allergic airways disease: development oftolerance using environmental antigens. J. Allergy Clin. Immunol.,2006; 118: 143-151
  Google Scholar
• 63. Wang Y.H., Liu Y.J.: Thymic stromal lymphopoietin, OX40-ligand,and interleukin-25 in allergic responses. Clin. Exp. Allergy,2009; 39: 798-806
  Google Scholar
• 64. Zhou B., Comeau M.R., De Smedt T., Liggitt H.D., Dahl M.E., LewisD.B., Gyarmati D., Aye T., Campbell D.J., Ziegler S.F.: Thymic stromallymphopoietin as a key initiatior of allergic airway inflammation inmice. Nat. Immunol., 2005; 6: 1047-1053
  Google Scholar

Full text